KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis
AMS:PHIA - Euronext Amsterdam - NL0000009538 - Common Stock - Currency: EUR
PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 57 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year PHIA was profitable.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.37%, PHIA is in line with its industry, outperforming 42.11% of the companies in the same industry.
The Return On Equity of PHIA (3.19%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 3.56%, PHIA is in line with its industry, outperforming 43.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROIC | 3.56% |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
PHIA has a Profit Margin (2.07%) which is in line with its industry peers.
PHIA has a Operating Margin (5.39%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PHIA has declined.
The Gross Margin of PHIA (43.42%) is worse than 70.18% of its industry peers.
In the last couple of years the Gross Margin of PHIA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% |
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PHIA is destroying value.
Compared to 1 year ago, PHIA has less shares outstanding
PHIA has more shares outstanding than it did 5 years ago.
PHIA has a worse debt/assets ratio than last year.
2.2 Solvency
PHIA has an Altman-Z score of 1.81. This is a bad value and indicates that PHIA is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.81, PHIA is in line with its industry, outperforming 47.37% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.60. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
PHIA's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. PHIA is outperformed by 68.42% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.81 |
ROIC/WACC0.57
WACC6.2%
2.3 Liquidity
A Current Ratio of 1.28 indicates that PHIA should not have too much problems paying its short term obligations.
PHIA has a Current ratio of 1.28. This is in the lower half of the industry: PHIA underperforms 63.16% of its industry peers.
PHIA has a Quick Ratio of 1.28. This is a bad value and indicates that PHIA is not financially healthy enough and could expect problems in meeting its short term obligations.
PHIA has a Quick ratio of 0.79. This is in the lower half of the industry: PHIA underperforms 64.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 7.45% over the past year.
The Earnings Per Share has been decreasing by -7.17% on average over the past years.
Looking at the last year, PHIA shows a decrease in Revenue. The Revenue has decreased by -0.89% in the last year.
The Revenue has been growing slightly by 1.00% on average over the past years.
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
3.2 Future
Based on estimates for the next years, PHIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.40% on average per year.
The Revenue is expected to grow by 3.10% on average over the next years.
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.98 indicates a correct valuation of PHIA.
PHIA's Price/Earnings ratio is rather cheap when compared to the industry. PHIA is cheaper than 91.23% of the companies in the same industry.
PHIA is valuated rather cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 11.99, the valuation of PHIA can be described as reasonable.
Based on the Price/Forward Earnings ratio, PHIA is valued cheaply inside the industry as 84.21% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 21.76. PHIA is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.98 | ||
| Fwd PE | 11.99 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 80.70% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 10.91 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 12.13% in the coming years.
PEG (NY)1.51
PEG (5Y)N/A
EPS Next 2Y11.54%
EPS Next 3Y12.13%
5. Dividend
5.1 Amount
No dividends for PHIA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMS:PHIA (7/9/2025, 3:46:52 PM)
20.67
+0.06 (+0.29%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners42.8%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap19.43B
Analysts73.08
Price Target26.21 (26.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.27%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.14%
Min EPS beat(2)-11.97%
Max EPS beat(2)22.24%
EPS beat(4)1
Avg EPS beat(4)-3.31%
Min EPS beat(4)-16.56%
Max EPS beat(4)22.24%
EPS beat(8)2
Avg EPS beat(8)-6.4%
EPS beat(12)4
Avg EPS beat(12)8.51%
EPS beat(16)5
Avg EPS beat(16)1.66%
Revenue beat(2)0
Avg Revenue beat(2)-2.5%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.17%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.16%
Revenue beat(12)2
Avg Revenue beat(12)-1.77%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-7.87%
PT rev (3m)-9.67%
EPS NQ rev (1m)-6.21%
EPS NQ rev (3m)-25.86%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.31%
Revenue NQ rev (1m)-2.12%
Revenue NQ rev (3m)-5.96%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.98 | ||
| Fwd PE | 11.99 | ||
| P/S | 1.08 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.66 | ||
| P/tB | N/A | ||
| EV/EBITDA | 10.91 |
EPS(TTM)1.38
EY6.68%
EPS(NY)1.72
Fwd EY8.34%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS19.13
BVpS12.44
TBVpS-1.36
PEG (NY)1.51
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.37% | ||
| ROE | 3.19% | ||
| ROCE | 4.75% | ||
| ROIC | 3.56% | ||
| ROICexc | 3.78% | ||
| ROICexgc | 11.65% | ||
| OM | 5.39% | ||
| PM (TTM) | 2.07% | ||
| GM | 43.42% | ||
| FCFM | N/A |
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-ScoreN/A
Asset Turnover0.66
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.6 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 2.99 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.28 | ||
| Quick Ratio | 0.79 | ||
| Altman-Z | 1.81 |
F-ScoreN/A
WACC6.2%
ROIC/WACC0.57
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.45%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%-3.85%
EPS Next Y9.94%
EPS Next 2Y11.54%
EPS Next 3Y12.13%
EPS Next 5Y12.4%
Revenue 1Y (TTM)-0.89%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-0.99%
Revenue Next Year1.15%
Revenue Next 2Y2.61%
Revenue Next 3Y3.12%
Revenue Next 5Y3.1%
EBIT growth 1Y379.25%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year50.08%
EBIT Next 3Y20.59%
EBIT Next 5YN/A
FCF growth 1Y-45.51%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y-31.12%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%